 Martin Boublik
Concepts (309)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Football | 8 | 2022 | 89 | 2.330 |
Why?
| | Tendon Injuries | 5 | 2018 | 73 | 1.270 |
Why?
| | Ribosomes | 30 | 1994 | 191 | 1.140 |
Why?
| | Soccer | 1 | 2022 | 38 | 0.730 |
Why?
| | Return to Sport | 1 | 2022 | 117 | 0.700 |
Why?
| | Escherichia coli | 33 | 1994 | 854 | 0.580 |
Why?
| | Pectoralis Muscles | 1 | 2018 | 17 | 0.570 |
Why?
| | RNA, Ribosomal | 15 | 1994 | 168 | 0.540 |
Why?
| | Ribosomal Proteins | 17 | 1994 | 91 | 0.540 |
Why?
| | Knee Injuries | 4 | 2011 | 122 | 0.460 |
Why?
| | Athletic Injuries | 4 | 2022 | 569 | 0.430 |
Why?
| | Brain Concussion | 1 | 2022 | 640 | 0.430 |
Why?
| | Patellar Ligament | 2 | 2011 | 26 | 0.370 |
Why?
| | Anterior Cruciate Ligament Injuries | 3 | 2011 | 216 | 0.350 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2010 | 13 | 0.330 |
Why?
| | Arthritis, Infectious | 1 | 2010 | 72 | 0.300 |
Why?
| | Groin | 1 | 2009 | 13 | 0.300 |
Why?
| | Orthopedic Procedures | 1 | 2011 | 243 | 0.280 |
Why?
| | Arthroscopy | 2 | 2025 | 267 | 0.270 |
Why?
| | Microscopy, Electron | 26 | 1993 | 415 | 0.240 |
Why?
| | Synovectomy | 1 | 2025 | 8 | 0.230 |
Why?
| | Meniscectomy | 1 | 2025 | 18 | 0.230 |
Why?
| | Synovitis | 1 | 2025 | 33 | 0.230 |
Why?
| | RNA, Ribosomal, 16S | 4 | 1991 | 558 | 0.200 |
Why?
| | Nucleic Acid Conformation | 17 | 1994 | 726 | 0.200 |
Why?
| | Osteoarthritis, Knee | 1 | 2025 | 279 | 0.180 |
Why?
| | Anterior Cruciate Ligament | 2 | 2011 | 101 | 0.160 |
Why?
| | Postoperative Complications | 2 | 2010 | 2919 | 0.150 |
Why?
| | RNA, Transfer | 6 | 1991 | 144 | 0.150 |
Why?
| | Athletes | 1 | 2022 | 419 | 0.140 |
Why?
| | Recovery of Function | 2 | 2013 | 707 | 0.140 |
Why?
| | Circular Dichroism | 17 | 1990 | 150 | 0.130 |
Why?
| | Microscopy, Electron, Scanning | 7 | 1994 | 199 | 0.130 |
Why?
| | Artemia | 4 | 1992 | 8 | 0.120 |
Why?
| | RNA, Transfer, Amino Acyl | 3 | 1993 | 9 | 0.120 |
Why?
| | Treatment Outcome | 6 | 2025 | 11679 | 0.120 |
Why?
| | Rupture | 2 | 2013 | 91 | 0.110 |
Why?
| | Thigh | 2 | 2013 | 47 | 0.110 |
Why?
| | Macromolecular Substances | 8 | 1993 | 224 | 0.100 |
Why?
| | Return to Work | 1 | 2013 | 21 | 0.100 |
Why?
| | Peptide Elongation Factor Tu | 1 | 1993 | 5 | 0.100 |
Why?
| | Molecular Weight | 5 | 1993 | 327 | 0.100 |
Why?
| | Transplantation, Autologous | 2 | 2011 | 290 | 0.100 |
Why?
| | Shoulder Injuries | 1 | 1993 | 66 | 0.100 |
Why?
| | Humans | 20 | 2025 | 144759 | 0.090 |
Why?
| | Microscopy, Electron, Scanning Transmission | 1 | 1992 | 3 | 0.090 |
Why?
| | Transplantation, Homologous | 2 | 2011 | 415 | 0.090 |
Why?
| | Retrospective Studies | 5 | 2025 | 17066 | 0.090 |
Why?
| | Knee Prosthesis | 1 | 1993 | 28 | 0.090 |
Why?
| | Arthritis, Juvenile | 1 | 1993 | 56 | 0.090 |
Why?
| | Quadriceps Muscle | 1 | 2013 | 118 | 0.090 |
Why?
| | Adult | 8 | 2025 | 40449 | 0.090 |
Why?
| | Protein Conformation | 13 | 1994 | 946 | 0.090 |
Why?
| | Rotator Cuff | 1 | 2012 | 59 | 0.090 |
Why?
| | Nucleotides | 2 | 1991 | 128 | 0.090 |
Why?
| | Suture Techniques | 1 | 2012 | 131 | 0.090 |
Why?
| | RNA, Fungal | 1 | 1991 | 73 | 0.080 |
Why?
| | RNA, Ribosomal, 18S | 1 | 1990 | 27 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 3 | 2011 | 3863 | 0.080 |
Why?
| | Poliovirus | 3 | 1990 | 73 | 0.080 |
Why?
| | Tendons | 1 | 2011 | 129 | 0.080 |
Why?
| | Protein Biosynthesis | 5 | 1991 | 458 | 0.080 |
Why?
| | RNA, Ribosomal, 23S | 1 | 1990 | 12 | 0.080 |
Why?
| | Medial Collateral Ligament, Knee | 1 | 2009 | 7 | 0.080 |
Why?
| | Peptides | 3 | 1994 | 995 | 0.080 |
Why?
| | Male | 15 | 2025 | 72315 | 0.070 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 1 | 2011 | 192 | 0.070 |
Why?
| | Interferon Type I | 1 | 1990 | 145 | 0.070 |
Why?
| | Health Care Costs | 1 | 2011 | 427 | 0.070 |
Why?
| | Saccharomyces cerevisiae | 1 | 1991 | 579 | 0.060 |
Why?
| | RNA, Bacterial | 3 | 1988 | 189 | 0.060 |
Why?
| | Osmolar Concentration | 4 | 1991 | 167 | 0.060 |
Why?
| | Buffers | 3 | 1990 | 55 | 0.060 |
Why?
| | Minimal Clinically Important Difference | 1 | 2025 | 30 | 0.060 |
Why?
| | Young Adult | 3 | 2013 | 14105 | 0.060 |
Why?
| | Knee Joint | 2 | 2002 | 426 | 0.050 |
Why?
| | Peptide Initiation Factors | 1 | 1983 | 16 | 0.050 |
Why?
| | Heel | 1 | 2002 | 9 | 0.050 |
Why?
| | Contracture | 1 | 2002 | 23 | 0.050 |
Why?
| | HeLa Cells | 4 | 1990 | 650 | 0.040 |
Why?
| | Female | 8 | 2025 | 78271 | 0.040 |
Why?
| | Quality-Adjusted Life Years | 2 | 2012 | 121 | 0.040 |
Why?
| | Probability | 2 | 2012 | 310 | 0.040 |
Why?
| | Anticodon | 3 | 1988 | 24 | 0.040 |
Why?
| | Range of Motion, Articular | 2 | 1993 | 421 | 0.040 |
Why?
| | Muscle, Skeletal | 1 | 2010 | 1795 | 0.040 |
Why?
| | Affinity Labels | 1 | 1980 | 25 | 0.040 |
Why?
| | Dictyostelium | 1 | 1980 | 11 | 0.040 |
Why?
| | Halobacterium | 1 | 1979 | 3 | 0.040 |
Why?
| | Geobacillus stearothermophilus | 1 | 1979 | 12 | 0.040 |
Why?
| | Nucleic Acid Denaturation | 3 | 1990 | 32 | 0.040 |
Why?
| | Morphogenesis | 2 | 1991 | 173 | 0.040 |
Why?
| | Ribonucleoproteins | 3 | 1991 | 103 | 0.040 |
Why?
| | Cost-Benefit Analysis | 2 | 2012 | 634 | 0.040 |
Why?
| | Lithium | 1 | 1978 | 42 | 0.040 |
Why?
| | Risk Factors | 1 | 2013 | 10779 | 0.040 |
Why?
| | Protein Binding | 5 | 1991 | 2273 | 0.030 |
Why?
| | Viral Proteins | 2 | 1981 | 355 | 0.030 |
Why?
| | Leg Injuries | 2 | 2013 | 23 | 0.030 |
Why?
| | Temperature | 4 | 1989 | 679 | 0.030 |
Why?
| | Cell Cycle | 1 | 1980 | 596 | 0.030 |
Why?
| | Polyribonucleotides | 1 | 1976 | 1 | 0.030 |
Why?
| | Liver | 2 | 1983 | 1887 | 0.030 |
Why?
| | Binding Sites | 7 | 1988 | 1329 | 0.030 |
Why?
| | RNA, Viral | 2 | 1980 | 688 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 2 | 1992 | 780 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2009 | 6048 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 1990 | 2930 | 0.030 |
Why?
| | Eukaryotic Cells | 2 | 1988 | 40 | 0.030 |
Why?
| | Bacterial Proteins | 4 | 1991 | 955 | 0.030 |
Why?
| | Cyclic GMP | 1 | 1975 | 92 | 0.030 |
Why?
| | Fluorenes | 1 | 1975 | 46 | 0.030 |
Why?
| | Structure-Activity Relationship | 3 | 1990 | 570 | 0.030 |
Why?
| | Computers | 2 | 1986 | 67 | 0.030 |
Why?
| | Protein Denaturation | 2 | 1990 | 75 | 0.030 |
Why?
| | Models, Structural | 4 | 1988 | 41 | 0.030 |
Why?
| | Guanosine Triphosphate | 2 | 1993 | 89 | 0.030 |
Why?
| | Palpation | 1 | 1993 | 15 | 0.020 |
Why?
| | Thermus thermophilus | 1 | 1993 | 21 | 0.020 |
Why?
| | Tobacco Mosaic Virus | 1 | 1992 | 3 | 0.020 |
Why?
| | Shoulder | 1 | 1993 | 105 | 0.020 |
Why?
| | Statistics as Topic | 2 | 1984 | 284 | 0.020 |
Why?
| | Histones | 3 | 1975 | 669 | 0.020 |
Why?
| | Peripheral Vascular Diseases | 1 | 1993 | 104 | 0.020 |
Why?
| | RNA | 2 | 1976 | 940 | 0.020 |
Why?
| | Fractures, Spontaneous | 1 | 1992 | 15 | 0.020 |
Why?
| | Physical Examination | 1 | 1993 | 239 | 0.020 |
Why?
| | Organogold Compounds | 1 | 1991 | 5 | 0.020 |
Why?
| | Decision Trees | 1 | 2011 | 81 | 0.020 |
Why?
| | Peptide Biosynthesis | 1 | 1991 | 13 | 0.020 |
Why?
| | Base Sequence | 3 | 1990 | 2190 | 0.020 |
Why?
| | X-Ray Diffraction | 1 | 1991 | 103 | 0.020 |
Why?
| | Methyltransferases | 1 | 1991 | 74 | 0.020 |
Why?
| | Movement | 1 | 1993 | 293 | 0.020 |
Why?
| | Joint Instability | 1 | 1993 | 182 | 0.020 |
Why?
| | Electron Probe Microanalysis | 1 | 1990 | 3 | 0.020 |
Why?
| | Shoulder Joint | 1 | 1993 | 198 | 0.020 |
Why?
| | Hydroxyapatites | 1 | 1990 | 16 | 0.020 |
Why?
| | DNA Helicases | 3 | 1981 | 143 | 0.020 |
Why?
| | Middle Aged | 4 | 2025 | 35875 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1990 | 157 | 0.020 |
Why?
| | Prosthesis Design | 1 | 1993 | 357 | 0.020 |
Why?
| | Gold | 1 | 1991 | 115 | 0.020 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1990 | 141 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 1991 | 112 | 0.020 |
Why?
| | Muscle Contraction | 1 | 1993 | 429 | 0.020 |
Why?
| | Radiography | 1 | 1993 | 844 | 0.020 |
Why?
| | Phosphorus | 1 | 1990 | 99 | 0.020 |
Why?
| | Staining and Labeling | 2 | 1982 | 151 | 0.020 |
Why?
| | Antibody-Dependent Cell Cytotoxicity | 1 | 1989 | 21 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 331 | 0.020 |
Why?
| | Reoperation | 1 | 2012 | 630 | 0.020 |
Why?
| | Antigens, Surface | 1 | 1989 | 157 | 0.020 |
Why?
| | Bone Neoplasms | 1 | 1992 | 253 | 0.020 |
Why?
| | Computer Simulation | 1 | 1994 | 1025 | 0.020 |
Why?
| | RNA, Transfer, Amino Acid-Specific | 1 | 1988 | 4 | 0.020 |
Why?
| | RNA, Transfer, Val | 1 | 1988 | 3 | 0.020 |
Why?
| | Polynucleotides | 2 | 1980 | 14 | 0.020 |
Why?
| | Animals | 13 | 1992 | 38058 | 0.020 |
Why?
| | Genes, Bacterial | 2 | 1987 | 166 | 0.020 |
Why?
| | Hydrogen Bonding | 1 | 1988 | 169 | 0.020 |
Why?
| | Prokaryotic Cells | 1 | 1988 | 6 | 0.020 |
Why?
| | Spectrophotometry, Ultraviolet | 3 | 1980 | 85 | 0.020 |
Why?
| | Decision Support Techniques | 1 | 2012 | 456 | 0.020 |
Why?
| | Thermodynamics | 1 | 1990 | 426 | 0.020 |
Why?
| | Models, Biological | 3 | 1984 | 1821 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 1990 | 1370 | 0.020 |
Why?
| | Proteins | 1 | 1973 | 1021 | 0.020 |
Why?
| | Water | 1 | 1990 | 469 | 0.020 |
Why?
| | Capsid | 2 | 1977 | 94 | 0.020 |
Why?
| | Drug Stability | 2 | 1979 | 164 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1990 | 2155 | 0.010 |
Why?
| | Molecular Conformation | 3 | 1978 | 148 | 0.010 |
Why?
| | Cell Nucleus | 2 | 1981 | 618 | 0.010 |
Why?
| | Cricetinae | 1 | 1985 | 303 | 0.010 |
Why?
| | Calcium | 1 | 1990 | 1183 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 1992 | 3409 | 0.010 |
Why?
| | Species Specificity | 2 | 1989 | 574 | 0.010 |
Why?
| | DNA | 1 | 1971 | 1463 | 0.010 |
Why?
| | Eukaryotic Initiation Factor-3 | 1 | 1983 | 10 | 0.010 |
Why?
| | Azides | 2 | 1984 | 47 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 1993 | 5408 | 0.010 |
Why?
| | Monosaccharide Transport Proteins | 1 | 1983 | 56 | 0.010 |
Why?
| | Symporters | 1 | 1983 | 48 | 0.010 |
Why?
| | Kinetics | 3 | 1991 | 1627 | 0.010 |
Why?
| | Pattern Recognition, Automated | 1 | 1982 | 74 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 1989 | 1519 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1983 | 1047 | 0.010 |
Why?
| | Membrane Transport Proteins | 1 | 1983 | 154 | 0.010 |
Why?
| | Nucleoproteins | 1 | 1981 | 38 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 1989 | 1982 | 0.010 |
Why?
| | Benzopyrenes | 2 | 1978 | 4 | 0.010 |
Why?
| | Escherichia coli Proteins | 1 | 1983 | 206 | 0.010 |
Why?
| | Cell Line | 1 | 1985 | 2882 | 0.010 |
Why?
| | Photolysis | 1 | 1980 | 94 | 0.010 |
Why?
| | DNA, Single-Stranded | 1 | 1980 | 119 | 0.010 |
Why?
| | Photochemistry | 1 | 1980 | 134 | 0.010 |
Why?
| | Immunoglobulin G | 2 | 1989 | 893 | 0.010 |
Why?
| | Cross-Linking Reagents | 1 | 1980 | 207 | 0.010 |
Why?
| | Arm Injuries | 1 | 1999 | 24 | 0.010 |
Why?
| | Adolescent | 2 | 2002 | 22428 | 0.010 |
Why?
| | Antibodies | 2 | 1984 | 401 | 0.010 |
Why?
| | Phenylalanine | 1 | 1979 | 71 | 0.010 |
Why?
| | Ethers, Cyclic | 1 | 1978 | 11 | 0.010 |
Why?
| | DNA, Viral | 1 | 1980 | 358 | 0.010 |
Why?
| | Oligoribonucleotides | 1 | 1978 | 52 | 0.010 |
Why?
| | Epoxy Compounds | 1 | 1978 | 32 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 1985 | 1496 | 0.010 |
Why?
| | Bacteria | 1 | 1985 | 889 | 0.010 |
Why?
| | Kidney | 1 | 1985 | 1495 | 0.010 |
Why?
| | Oligonucleotides | 1 | 1978 | 151 | 0.010 |
Why?
| | Antigen-Antibody Reactions | 1 | 1976 | 50 | 0.010 |
Why?
| | Solvents | 2 | 1978 | 113 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2002 | 2115 | 0.010 |
Why?
| | Methods | 2 | 1973 | 69 | 0.010 |
Why?
| | Polyribosomes | 1 | 1975 | 22 | 0.010 |
Why?
| | Spectrum Analysis | 2 | 1973 | 93 | 0.010 |
Why?
| | Cattle | 3 | 1975 | 1000 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 1975 | 630 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 1985 | 2608 | 0.010 |
Why?
| | United States | 1 | 2013 | 15966 | 0.010 |
Why?
| | Isomerism | 1 | 1975 | 57 | 0.010 |
Why?
| | Chromatography, Ion Exchange | 1 | 1975 | 57 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 2 | 1975 | 561 | 0.010 |
Why?
| | Phenobarbital | 1 | 1974 | 19 | 0.010 |
Why?
| | Acetamides | 1 | 1975 | 37 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 1981 | 1499 | 0.010 |
Why?
| | Serotonin | 1 | 1975 | 293 | 0.010 |
Why?
| | Guanidines | 1 | 1973 | 41 | 0.010 |
Why?
| | Pharmaceutical Preparations | 1 | 1974 | 170 | 0.010 |
Why?
| | Urea | 1 | 1973 | 84 | 0.010 |
Why?
| | Mice | 3 | 1989 | 18339 | 0.010 |
Why?
| | Cytosine | 1 | 1991 | 51 | 0.010 |
Why?
| | Rehabilitation Centers | 1 | 1992 | 39 | 0.010 |
Why?
| | 5-Methylcytosine | 1 | 1991 | 25 | 0.010 |
Why?
| | Guanine | 1 | 1991 | 87 | 0.010 |
Why?
| | Methylation | 1 | 1991 | 242 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1991 | 388 | 0.010 |
Why?
| | Chromatin | 1 | 1975 | 561 | 0.010 |
Why?
| | Durapatite | 1 | 1990 | 36 | 0.010 |
Why?
| | Models, Molecular | 2 | 1991 | 1618 | 0.000 |
Why?
| | Reference Standards | 1 | 1990 | 177 | 0.000 |
Why?
| | Thymectomy | 1 | 1989 | 15 | 0.000 |
Why?
| | Prospective Studies | 1 | 2002 | 7990 | 0.000 |
Why?
| | Mice, Inbred Strains | 1 | 1989 | 397 | 0.000 |
Why?
| | Immunoglobulin M | 1 | 1989 | 284 | 0.000 |
Why?
| | T-Phages | 1 | 1987 | 18 | 0.000 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 1987 | 63 | 0.000 |
Why?
| | Ligands | 1 | 1988 | 673 | 0.000 |
Why?
| | Plasmids | 1 | 1987 | 379 | 0.000 |
Why?
| | Flow Cytometry | 1 | 1989 | 1173 | 0.000 |
Why?
| | DNA, Recombinant | 1 | 1985 | 48 | 0.000 |
Why?
| | Cell-Free System | 1 | 1985 | 53 | 0.000 |
Why?
| | Genes | 1 | 1985 | 226 | 0.000 |
Why?
| | Antigen-Antibody Complex | 1 | 1984 | 72 | 0.000 |
Why?
| | Sodium Chloride | 2 | 1975 | 141 | 0.000 |
Why?
| | Genetic Engineering | 1 | 1985 | 93 | 0.000 |
Why?
| | Thymus Gland | 2 | 1975 | 311 | 0.000 |
Why?
| | Cloning, Molecular | 1 | 1985 | 540 | 0.000 |
Why?
| | gamma-Aminobutyric Acid | 1 | 1984 | 192 | 0.000 |
Why?
| | Epitopes | 1 | 1984 | 485 | 0.000 |
Why?
| | Promoter Regions, Genetic | 1 | 1985 | 1257 | 0.000 |
Why?
| | Dinitrophenols | 1 | 1979 | 7 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1992 | 8265 | 0.000 |
Why?
| | Nucleic Acids | 1 | 1979 | 72 | 0.000 |
Why?
| | Valine | 1 | 1979 | 80 | 0.000 |
Why?
| | Immunoassay | 1 | 1979 | 109 | 0.000 |
Why?
| | Chemistry | 1 | 1978 | 41 | 0.000 |
Why?
| | Chemical Phenomena | 1 | 1978 | 81 | 0.000 |
Why?
| | Centrifugation, Density Gradient | 1 | 1976 | 40 | 0.000 |
Why?
| | Carcinoma, Ehrlich Tumor | 1 | 1975 | 1 | 0.000 |
Why?
| | Puromycin | 1 | 1975 | 10 | 0.000 |
Why?
| | Cycloheximide | 1 | 1975 | 46 | 0.000 |
Why?
| | Aminoacylation | 1 | 1975 | 14 | 0.000 |
Why?
| | Mutation | 1 | 1987 | 4089 | 0.000 |
Why?
| | Reserpine | 1 | 1975 | 2 | 0.000 |
Why?
| | Sea Urchins | 1 | 1975 | 7 | 0.000 |
Why?
| | Adenylyl Cyclases | 1 | 1975 | 60 | 0.000 |
Why?
| | Spectrophotometry, Infrared | 1 | 1975 | 55 | 0.000 |
Why?
| | Binding, Competitive | 1 | 1975 | 193 | 0.000 |
Why?
| | Dealkylation | 1 | 1974 | 3 | 0.000 |
Why?
| | Cytochrome Reductases | 1 | 1974 | 3 | 0.000 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 1974 | 17 | 0.000 |
Why?
| | Hydroxylation | 1 | 1974 | 49 | 0.000 |
Why?
| | Mixed Function Oxygenases | 1 | 1974 | 49 | 0.000 |
Why?
| | Microsomes, Liver | 1 | 1974 | 85 | 0.000 |
Why?
| | Guinea Pigs | 1 | 1974 | 159 | 0.000 |
Why?
| | Rabbits | 1 | 1975 | 648 | 0.000 |
Why?
| | Myocardial Contraction | 1 | 1975 | 298 | 0.000 |
Why?
| | Aniline Compounds | 1 | 1974 | 119 | 0.000 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1974 | 162 | 0.000 |
Why?
| | Guanine Nucleotides | 1 | 1972 | 12 | 0.000 |
Why?
| | Neoplasm Proteins | 1 | 1975 | 442 | 0.000 |
Why?
| | Animals, Newborn | 1 | 1974 | 902 | 0.000 |
Why?
| | Piperazines | 1 | 1974 | 381 | 0.000 |
Why?
| | Blood Platelets | 1 | 1975 | 400 | 0.000 |
Why?
| | Postpartum Period | 1 | 1974 | 365 | 0.000 |
Why?
| | Aged | 1 | 1992 | 25913 | 0.000 |
Why?
| | Amino Acids | 1 | 1975 | 521 | 0.000 |
Why?
| | Gestational Age | 1 | 1974 | 975 | 0.000 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1975 | 2027 | 0.000 |
Why?
| | Fetus | 1 | 1974 | 803 | 0.000 |
Why?
| | Adenosine Triphosphate | 1 | 1972 | 498 | 0.000 |
Why?
| | RNA, Messenger | 1 | 1976 | 2832 | 0.000 |
Why?
| | Rats | 1 | 1975 | 5597 | 0.000 |
Why?
| | Anti-Bacterial Agents | 1 | 1975 | 1907 | 0.000 |
Why?
| | Mice, Inbred C57BL | 1 | 1975 | 5992 | 0.000 |
Why?
| | Aging | 1 | 1974 | 1966 | 0.000 |
Why?
| | Pregnancy | 1 | 1974 | 7190 | 0.000 |
Why?
|
|
Boublik's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|